Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CLS-001 by Cellusion for Corneal Edema: Likelihood of Approval
CLS-001 is under clinical development by Cellusion and currently in Phase I for Corneal Edema. According to GlobalData, Phase I...